drugset / Trial / NCT02567578
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2 trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-03-16
- Completion
- 2017-03-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YH12852 | Unknown | 0.1 mg | Oral |
| Subject | YH12852 | Unknown | 0.25 mg | Oral |
| Subject | YH12852 | Unknown | 0.5 mg | Oral |